4538 — Fuso Pharmaceutical Industries Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Fuso Pharmaceutical Industries, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,911 | 2,205 | 1,767 | -4,970 | 2,438 |
| Depreciation | |||||
| Non-Cash Items | 46 | -59 | 25 | 8,774 | -188 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,019 | -1,779 | -3,427 | -9,464 | -11,092 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,497 | 2,853 | 628 | -3,306 | -6,224 |
| Capital Expenditures | -1,487 | -1,574 | -3,588 | -3,098 | -1,659 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -66 | 201 | 52 | -70 | 144 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,553 | -1,373 | -3,536 | -3,168 | -1,515 |
| Financing Cash Flow Items | -1 | -1 | -2 | -308 | -116 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,671 | -813 | 14 | 7,618 | 6,321 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 273 | 667 | -2,894 | 1,144 | -1,418 |